STIRLING, Scotland – 22nd September 2017 – eClinicalHealth Limited, a cloud-based eClinical technology company, announces continued expansion in patient-centric trial models and increased therapeutic areas.
With nearly six years of delivery experience, Clinpal has recently launched new studies to support the important needs of biopharmaceutical and CRO clients seeking patient-friendly clinical study solutions. This has included work in Rare Diseases, Cystic Fibrosis, Otolaryngology, CNS, Oncology, Women’s Health, and Gastroenterology. The company continues its expansion in Social Research, Rx-to-OTC switch, and Consumer Care projects.
“We are extremely proud of achieving our mission to bring the convenience of patient-centricity to the clinical research process,” said Karl Landert, CEO of eClinicalHealth. “With the proprietary functionality of Clinpal’s patient dashboards and the use of patients’ own personal devices, we have established the trend-setting pace in remote research, allowing our biopharmaceutical and CRO clients to realize reduced costs and timelines through our direct-to-patient research models.”
Read more about Clinpal achievements here.
Headquartered in Scotland, eClinicalHealth Limited, developers of the revolutionary Clinpal patient engagement platform, was founded in early 2012 to provide innovative clinical trial solutions. The company is committed to leading open and collaborative innovation discussions about patient-centric clinical trial processes and technology with pharmaceutical companies, CROs, and other service and technology providers.